The post Prediction Market Kalshi Faces Class Action Over Iran War-Linked Bets appeared on BitcoinEthereumNews.com. A proposed class action lawsuit now targets The post Prediction Market Kalshi Faces Class Action Over Iran War-Linked Bets appeared on BitcoinEthereumNews.com. A proposed class action lawsuit now targets

Prediction Market Kalshi Faces Class Action Over Iran War-Linked Bets

For feedback or concerns regarding this content, please contact us at [email protected]

A proposed class action lawsuit now targets prediction market Kalshi after traders disputed payouts tied to bets on Ali Khamenei leaving office. The complaint, filed in the U.S. District Court for the Central District of California, followed reports of U.S. and Israeli airstrikes during the Iran War. Traders claim the platform halted a $54 million market while refusing expected payouts.

Iran War Market Dispute Draws Legal Challenge Against Kalshi

The lawsuit centers on a prediction contract asking whether Khamenei would leave office by specific deadlines before the Iran war even began. Trading volumes on the market reached about $54 million before the exchange halted activity on Feb. 28.

According to Bloomberg Law, traders argued the contract language promised full payouts if the Iranian leader exited the role. However, the platform later referenced a “death carveout” that excluded outcomes linked directly to a death.

Plaintiffs say Kalshi did not clearly disclose that exception when traders initially entered positions. Instead, they claim the rule appeared prominently only after reports of airstrikes in the Iran war began circulating.

Notably, traders say the platform allowed activity to continue while reports of strikes spread on Feb. 28. As a result, more participants reportedly placed “yes” positions expecting payouts if Khamenei left office on the Iran war.

This lawsuit comes days after CoinGape reported that Kalshi had fined a MrBeast associate over insider trading. The lawsuit argues that both traders and the platform understood the most realistic path for departure involved death. At the time, military tensions around Iran had escalated fast

Traders Adam Risch and Yonatan Gliksman Lead Lawsuit

Two traders, Adam Risch and Yonatan Gliksman, filed the proposed class action. The law firm Novian & Novian LLP represents them in the California federal court. Their proposed class includes U.S. traders who held “yes” positions across any expiration date when trading stopped.

Notably, this is not the only lawsuit against the prediction market, as it is facing another in Oregon for operating an “illegal online gambling enterprise” in violation of Oregon law that appeared even before the Iran war began.

Those contracts speculated on departure deadlines ranging from March 1 to later months. The plaintiffs seek damages and restitution tied to the halted market. They also request court orders requiring Kalshi to improve disclosure practices for similar markets.

Additionally, the complaint alleges breach of contract and violations of California law. It also demands the return of what plaintiffs describe as ill-gotten gains.

CEO Response and Broader Scrutiny of Prediction Markets

Following the controversy, Kalshi chief executive Tarek Mansour addressed the dispute. He stated the platform does not offer markets directly tied to a person’s death. However, criticism continued. Mansour later announced the company would reimburse fees and net losses connected to the disputed market.

He acknowledged traders felt the rules lacked enough visibility. Therefore, Kalshi decided to reimburse losses from the market out of pocket. The company also said it would update how similar contracts present death-related exceptions. Future listings, according to Mansour, will show those rules more clearly before trading begins.

Meanwhile, prediction markets face increasing regulatory attention across the United States. Several states argue event contracts resemble gambling under state law. By contrast, the federal regulator Commodity Futures Trading Commission treats these products as derivatives contracts. The agency has already filed an amicus brief to assert its jurisdiction over prediction markets. 

Amid the Iran War, Kalshi has listed the odds on a possible U.S.–Iran nuclear agreement. Traders estimate a 46% chance of a deal before 2027. They also place the probability at 35% before August and 9% before April.

Source: Kalshi

Source: https://coingape.com/prediction-market-kalshi-faces-class-action-over-iran-war-linked-bets/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09